NYSE:ABBV - AbbVie Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $121.67
  • Forecasted Upside: 3.15 %
  • Number of Analysts: 14
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 12 Buy Ratings
  • 0 Strong Buy Ratings
$117.96
▲ +0.17 (0.14%)

This chart shows the closing price for ABBV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AbbVie Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ABBV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ABBV

Analyst Price Target is $121.67
▲ +3.15% Upside Potential
This price target is based on 14 analysts offering 12 month price targets for AbbVie in the last 3 months. The average price target is $121.67, with a high forecast of $144.00 and a low forecast of $98.00. The average price target represents a 3.15% upside from the last price of $117.96.

This chart shows the closing price for ABBV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 14 polled investment analysts is to buy stock in AbbVie. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 9 buy ratings
  • 2 hold ratings
  • 2 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 9 buy ratings
  • 3 hold ratings
  • 1 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 3 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/31/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 4 hold ratings
  • 1 sell ratings
1/29/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/29/2021
  • 0 strong buy ratings
  • 10 buy ratings
  • 1 hold ratings
  • 1 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 1 sell ratings
7/28/2021

Latest Recommendations

  • 0 strong buy ratings
  • 12 buy ratings
  • 1 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/27/2021Truist SecuritiesInitiated CoverageBuy$117.00Low
7/27/2021TruistInitiated CoverageBuy$118.00 ➝ $124.08Low
7/2/2021Daiwa Capital MarketsInitiated CoverageOutperformLow
5/3/2021BMO Capital MarketsBoost Price TargetOutperform$127.00 ➝ $129.00High
5/3/2021MizuhoBoost Price TargetBuy$126.00 ➝ $128.00High
4/30/2021Piper SandlerBoost Price TargetOverweight$120.00 ➝ $124.00Low
4/7/2021Royal Bank of CanadaInitiated Coverage$135.00Low
3/30/2021SVB LeerinkBoost Price TargetOutperform$140.00 ➝ $144.00Low
2/4/2021SVB LeerinkBoost Price TargetIn-Line ➝ Outperform$128.00 ➝ $140.00Low
2/4/2021Royal Bank of CanadaBoost Price TargetOutperform$129.00 ➝ $135.00Low
2/4/2021MizuhoBoost Price TargetBuy$117.00 ➝ $126.00Low
1/28/2021Morgan StanleyLower Price TargetOverweight$120.00 ➝ $116.00Medium
12/16/2020SVB LeerinkBoost Price TargetOutperform$119.00 ➝ $128.00Medium
12/15/2020MizuhoBoost Price Target$111.00 ➝ $117.00Medium
11/30/2020Morgan StanleyBoost Price TargetPositive ➝ Overweight$108.00 ➝ $120.00Low
11/18/2020BMO Capital MarketsInitiated CoverageOutperform$123.00 ➝ $123.00Medium
11/10/2020Sanford C. BernsteinInitiated CoverageOutperform$120.00High
11/2/2020SVB LeerinkLower Price TargetOutperform$122.00 ➝ $119.00High
10/23/2020TruistInitiated CoverageBuy$110.00Low
10/20/2020The Goldman Sachs GroupDowngradeNeutral ➝ SellHigh
10/16/2020JPMorgan Chase & Co.Boost Price TargetOverweight$115.00 ➝ $120.00Low
9/29/2020Berenberg BankInitiated CoverageHold$98.00Low
9/27/2020MizuhoReiterated RatingBuy$111.00Low
9/2/2020CitigroupBoost Price TargetBuy$98.00 ➝ $105.00Medium
8/20/2020Morgan StanleyBoost Price TargetOverweight$95.00 ➝ $108.00Medium
8/3/2020MizuhoBoost Price TargetBuy$110.00 ➝ $111.00Low
8/3/2020Royal Bank of CanadaBoost Price TargetOutperform$125.00 ➝ $127.00Low
6/29/2020MizuhoBoost Price TargetTop Pick ➝ Buy$101.00 ➝ $110.00Low
6/25/2020Royal Bank of CanadaBoost Price TargetOutperform$102.00 ➝ $125.00Medium
6/23/2020Atlantic SecuritiesUpgradeNeutral ➝ Overweight$115.00Medium
6/18/2020Royal Bank of CanadaReiterated RatingBuy$102.00Low
6/17/2020UBS GroupBoost Price Target$96.00 ➝ $109.00Low
6/10/2020Evercore ISIInitiated CoverageBuy$111.00High
6/10/2020Piper SandlerBoost Price Target$97.00 ➝ $110.00High
6/9/2020Wolfe ResearchUpgradePeer Perform ➝ OutperformLow
6/2/2020ArgusUpgradeHold ➝ Buy$91.40 ➝ $115.00Low
5/28/2020Royal Bank of CanadaReiterated RatingBuy$102.00Low
5/18/2020Bank of AmericaInitiated CoverageNeutral$95.00Low
5/12/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$105.00Medium
5/11/2020Morgan StanleyReiterated RatingOverweight$95.00High
5/11/2020SVB LeerinkBoost Price TargetOutperform$107.00 ➝ $122.00High
5/4/2020SVB LeerinkBoost Price TargetOutperform$103.00 ➝ $107.00Low
5/1/2020MizuhoReiterated RatingBuy$100.00Medium
4/20/2020Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$79.00 ➝ $93.00Low
4/13/2020UBS GroupLower Price TargetBuy$106.00 ➝ $96.00Low
4/12/2020Royal Bank of CanadaReiterated RatingHold$79.00Low
3/23/2020Societe GeneraleDowngradeBuy ➝ HoldHigh
2/27/2020BarclaysInitiated CoverageEqual Weight$97.00 ➝ $97.00High
2/18/2020CowenBoost Price TargetOutperform$98.00 ➝ $105.00Low
2/10/2020MizuhoBoost Price Target$96.00 ➝ $104.00High
2/7/2020Piper SandlerBoost Price TargetOverweight$95.00 ➝ $97.00Low
2/5/2020MizuhoInitiated CoverageBuy$96.00 ➝ $96.00Low
1/23/2020Royal Bank of CanadaReiterated RatingHold$86.00High
1/6/2020Royal Bank of CanadaInitiated CoverageSector Perform$86.00Low
1/3/2020Bank of AmericaDowngradeBuy ➝ NeutralLow
12/26/2019CowenBoost Price TargetOutperform$90.00 ➝ $98.00Low
11/20/2019CitigroupBoost Price TargetBuy$90.00 ➝ $98.00Medium
11/19/2019UBS GroupBoost Price TargetBuy$79.00 ➝ $96.00High
11/1/2019Piper Jaffray CompaniesBoost Price Target$81.00 ➝ $90.00High
9/26/2019CitigroupUpgradeNeutral ➝ Buy$87.00 ➝ $90.00Medium
9/24/2019CowenSet Price TargetBuy$90.00Low
9/12/2019UBS GroupUpgradeNeutral ➝ Buy$85.00 ➝ $79.00Low
9/4/2019Piper Jaffray CompaniesBoost Price TargetOverweight$80.00 ➝ $81.00Medium
8/20/2019Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$80.00High
7/26/2019Piper Jaffray CompaniesSet Price TargetHold$80.00N/A
7/2/2019SVB LeerinkUpgradeBuyLow
6/27/2019Wolfe ResearchUpgradeUnderperform ➝ Peer PerformMedium
6/26/2019CitigroupReiterated RatingHoldMedium
6/26/2019SVB LeerinkUpgradeMarket Perform ➝ Outperform$88.00High
5/28/2019The Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$84.00High
4/28/2019BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$71.00 ➝ $79.00Low
4/26/2019Credit Suisse GroupSet Price TargetSell$78.00Low
3/25/2019ArgusDowngradeBuy ➝ HoldLow
2/14/2019BarclaysReiterated RatingHold$86.00Low
1/25/2019Credit Suisse GroupSet Price TargetHold$79.00High
1/23/2019UBS GroupReiterated RatingNeutral ➝ Neutral$97.00 ➝ $91.00Low
1/17/2019Credit Suisse GroupUpgradeHold$79.00Medium
1/3/2019Bank of AmericaDowngradeBuy ➝ NeutralMedium
12/26/2018Standpoint ResearchInitiated CoverageBuy ➝ BuyHigh
12/20/2018Morgan StanleySet Price TargetHold$88.00High
11/6/2018ArgusLower Price TargetBuy ➝ Buy$130.00 ➝ $115.00Low
11/5/2018BMO Capital MarketsLower Price TargetUnderperform ➝ Underperform$78.00 ➝ $71.00Low
11/4/2018BarclaysReiterated RatingHold$90.00High
11/2/2018Credit Suisse GroupSet Price TargetHold$85.00High
10/23/2018Wolfe ResearchInitiated CoverageUnderperformLow
10/22/2018SunTrust BanksLower Price TargetBuy ➝ Buy$157.00 ➝ $135.00High
10/20/2018Credit Suisse GroupSet Price TargetSell$85.00High
10/14/2018Credit Suisse GroupSet Price TargetHold$85.00Medium
10/4/2018Bank of AmericaLower Price TargetBuy ➝ Buy$107.00 ➝ $106.00Medium
8/22/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$105.00 ➝ $107.00Low
8/22/2018BMO Capital MarketsReiterated RatingSell$78.00Low
7/30/2018Bank of AmericaLower Price TargetBuy ➝ Buy$112.00 ➝ $105.00Medium
7/27/2018Piper Jaffray CompaniesReiterated RatingHold$100.00Low
7/27/2018CowenSet Price TargetBuy$110.00Low
7/27/2018BMO Capital MarketsReiterated RatingSell$78.00Low
7/15/2018Jefferies Financial GroupSet Price TargetBuy$100.00Low
7/13/2018Credit Suisse GroupUpgradeHold$89.00Low
7/12/2018Berenberg BankInitiated CoverageHold$105.00Low
6/11/2018ArgusLower Price TargetBuy ➝ Buy$145.00 ➝ $130.00Low
6/6/2018Credit Suisse GroupSet Price TargetSell$89.00Low
6/1/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$125.86 ➝ $66.62Low
5/30/2018Deutsche Bank AktiengesellschaftDowngradeNeutral ➝ Underperform$125.86 ➝ $65.61Medium
5/30/2018Deutsche Bank AktiengesellschaftDowngradeNeutral ➝ Underperform$125.86 ➝ $65.61Low
5/29/2018Credit Suisse GroupDowngradeNeutral ➝ Sell$104.00 ➝ $89.00Medium
5/24/2018The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyHigh
5/23/2018BMO Capital MarketsLower Price TargetUnderperform ➝ Underperform$81.00 ➝ $78.00Low
5/1/2018BMO Capital MarketsReiterated RatingSell$81.00Low
4/30/2018Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$131.00 ➝ $110.00High
4/27/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$109.00 ➝ $104.00Medium
4/22/2018Credit Suisse GroupSet Price TargetHold$109.00Low
4/13/2018Jefferies Financial GroupSet Price TargetBuy$122.00Low
4/10/2018Credit Suisse GroupSet Price TargetHold$109.00Low
4/5/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$120.00 ➝ $102.00Low
4/5/2018BMO Capital MarketsReiterated RatingSell$80.00Low
3/26/2018Bank of AmericaSet Price TargetHold$120.00High
3/23/2018Jefferies Financial GroupSet Price TargetBuy$125.00High
3/23/2018Credit Suisse GroupLower Price TargetNeutral$109.00 ➝ $98.10Medium
3/23/2018BMO Capital MarketsLower Price TargetUnderperform ➝ Underperform$95.00 ➝ $80.00Medium
3/22/2018BMO Capital MarketsSet Price TargetSell$95.00High
3/13/2018BMO Capital MarketsSet Price TargetSell$95.00Low
2/26/2018Jefferies Financial GroupSet Price TargetBuy$145.00Low
2/21/2018BMO Capital MarketsSet Price TargetSell$95.00Low
2/15/2018BMO Capital MarketsReiterated RatingSell$95.00High
2/15/2018Piper Jaffray CompaniesBoost Price TargetOverweight$130.00 ➝ $138.00High
2/2/2018ArgusBoost Price TargetBuy$120.00 ➝ $145.00Low
1/30/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$99.00 ➝ $131.00Low
1/29/2018Evercore ISIReiterated RatingBuy$144.00Low
1/29/2018Credit Suisse GroupSet Price TargetHold$98.00 ➝ $135.00Medium
1/29/2018BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$125.86 ➝ $84.00Low
1/29/2018SunTrust BanksBoost Price TargetBuy ➝ Average$157.00Low
1/29/2018SVB LeerinkDowngradeOutperform ➝ Market Perform$127.00Medium
1/26/2018Piper Jaffray CompaniesBoost Price TargetOutperform$115.00 ➝ $130.00Low
1/22/2018Credit Suisse GroupSet Price TargetHold$98.00Low
1/11/2018BMO Capital MarketsSet Price TargetHold$84.00Low
1/4/2018Jefferies Financial GroupBoost Price TargetBuy$115.00 ➝ $120.00Low
1/2/2018Piper Jaffray CompaniesReiterated RatingBuyHigh
12/20/2017BMO Capital MarketsSet Price TargetHold$84.00Medium
12/5/2017SVB LeerinkSet Price TargetBuy$106.00Low
12/4/2017BMO Capital MarketsSet Price TargetHold$84.00Low
11/21/2017BMO Capital MarketsReiterated RatingHold$84.00N/A
11/21/2017Societe GeneraleBoost Price TargetN/A
10/30/2017SunTrust BanksReiterated RatingBuyN/A
10/30/2017SVB LeerinkLower Price TargetOutperform$108.00 ➝ $107.00N/A
10/27/2017BMO Capital MarketsSet Price TargetHold$66.00N/A
10/27/2017Piper Jaffray CompaniesBoost Price TargetOverweight$115.00N/A
10/16/2017Jefferies Financial GroupBoost Price TargetBuy$107.00 ➝ $115.00N/A
10/13/2017BarclaysBoost Price TargetEqual Weight$90.00N/A
10/13/2017UBS GroupReiterated RatingNeutralN/A
10/11/2017CowenUpgradeMarket Perform ➝ Outperform$91.17 ➝ $105.00N/A
10/2/2017SVB LeerinkUpgradeMarket Perform ➝ Outperform$89.00 ➝ $106.00Medium
10/1/2017Credit Suisse GroupReiterated RatingNeutral$74.00 ➝ $94.00Medium
9/30/2017Evercore ISIReiterated RatingOutperform$95.00 ➝ $100.00Medium
9/29/2017ArgusBoost Price TargetBuy$90.00 ➝ $110.00Low
9/29/2017Morgan StanleyBoost Price TargetEqual Weight$70.00 ➝ $95.00Low
9/28/2017BarclaysReiterated RatingHold$68.00Low
9/28/2017BMO Capital MarketsReiterated RatingHold$66.00Low
9/28/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$88.00Low
9/28/2017Jefferies Financial GroupReiterated RatingBuy$107.00Medium
9/25/2017UBS GroupDowngradeBuy ➝ Neutral$79.00 ➝ $92.00Low
9/15/2017Jefferies Financial GroupReiterated RatingBuy ➝ Buy$94.00 ➝ $107.00High
9/15/2017Piper Jaffray CompaniesReiterated RatingBuy$100.00High
9/13/2017SunTrust BanksReiterated RatingBuy$95.00Low
9/12/2017SVB LeerinkReiterated RatingMarket PerformLow
9/11/2017CowenReiterated RatingMarket Perform ➝ Hold$70.00 ➝ $95.00Medium
9/8/2017The Goldman Sachs GroupReiterated RatingBuy$85.00 ➝ $100.00Low
9/8/2017Jefferies Financial GroupReiterated RatingBuy$94.00Low
8/16/2017Evercore ISIInitiated CoverageOutperform ➝ Outperform$95.00Medium
8/3/2017Piper Jaffray CompaniesReiterated RatingBuy$85.00Low
7/30/2017CowenSet Price TargetHold$70.00Low
7/20/2017Credit Suisse GroupReiterated RatingNeutral$65.00 ➝ $74.00Medium
7/17/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$65.00 ➝ $66.00Low
7/17/2017Jefferies Financial GroupReiterated RatingBuy$92.00 ➝ $94.00Low
6/22/2017SVB LeerinkReiterated RatingMarket PerformLow
6/22/2017Societe GeneraleUpgradeHold ➝ BuyLow
6/7/2017Credit Suisse GroupReiterated RatingHold$65.00Medium
5/26/2017Jefferies Financial GroupReiterated RatingBuyN/A
5/17/2017BMO Capital MarketsReiterated RatingMarket Perform$66.00Low
5/2/2017BMO Capital MarketsBoost Price TargetMarket Perform$63.00 ➝ $66.00Low
4/28/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$64.00 ➝ $65.00Low
4/27/2017BMO Capital MarketsSet Price TargetHold$63.00Medium
4/20/2017SVB LeerinkSet Price TargetHold$71.00Low
4/18/2017BMO Capital MarketsReiterated RatingHold$63.00Low
3/22/2017Societe GeneraleUpgradeSell ➝ HoldLow
3/22/2017BMO Capital MarketsReiterated RatingHold$63.00Low
3/11/2017The Goldman Sachs GroupUpgradeBuy ➝ Conviction-Buy$74.00 ➝ $80.00N/A
3/7/2017Jefferies Financial GroupReiterated RatingTop Pick ➝ Buy$4.30 ➝ $90.00N/A
2/14/2017Jefferies Financial GroupReiterated RatingBuy$90.00N/A
1/5/2017Jefferies Financial GroupReiterated RatingBuy$90.00N/A
12/8/2016William BlairReiterated RatingOutperform$76.00N/A
11/28/2016CitigroupDowngradeBuy ➝ Neutral$60.00N/A
11/8/2016SVB LeerinkReiterated RatingHoldN/A
11/8/2016BMO Capital MarketsReiterated RatingMarket Perform$63.00N/A
11/8/2016CitigroupReiterated RatingBuyN/A
11/1/2016Jefferies Financial GroupReiterated RatingBuy$90.00N/A
10/31/2016Credit Suisse GroupDowngradeOutperform ➝ Neutral$70.00 ➝ $60.00N/A
10/18/2016SVB LeerinkInitiated CoverageMarket Perform$70.00N/A
10/5/2016Jefferies Financial GroupReiterated RatingBuy$90.00N/A
9/27/2016The Goldman Sachs GroupReiterated RatingBuy$78.00N/A
9/8/2016The Goldman Sachs GroupReiterated RatingBuy$78.00N/A
9/8/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$75.00 ➝ $73.00N/A
9/7/2016UBS GroupReiterated RatingBuyN/A
9/1/2016Raymond JamesInitiated CoverageOutperform$82.00N/A
8/25/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/8/2016ArgusReiterated RatingBuy$85.00N/A
8/4/2016Jefferies Financial GroupReiterated RatingBuyN/A
8/2/2016BarclaysReiterated RatingEqual Weight$68.00N/A
7/29/2016BMO Capital MarketsReiterated RatingMarket Perform$66.00N/A
(Data available from 7/28/2016 forward)
AbbVie logo
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Read More

Today's Range

Now: $117.96
Low: $116.76
High: $118.30

50 Day Range

MA: $115.07
Low: $111.40
High: $118.19

52 Week Range

Now: $117.96
Low: $79.11
High: $118.67

Volume

3,731,599 shs

Average Volume

5,399,075 shs

Market Capitalization

$208.34 billion

P/E Ratio

41.68

Dividend Yield

4.41%

Beta

0.83

Frequently Asked Questions

What sell-side analysts currently cover shares of AbbVie?

The following sell-side analysts have issued research reports on AbbVie in the last year: Berenberg Bank, BMO Capital Markets, Citigroup Inc., Daiwa Capital Markets, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Piper Sandler, Royal Bank of Canada, Sanford C. Bernstein, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Securities, and Zacks Investment Research.
View the latest analyst ratings for ABBV.

What is the current price target for AbbVie?

12 Wall Street analysts have set twelve-month price targets for AbbVie in the last year. Their average twelve-month price target is $121.67, suggesting a possible upside of 3.1%. SVB Leerink LLC has the highest price target set, predicting ABBV will reach $144.00 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $98.00 for AbbVie in the next year.
View the latest price targets for ABBV.

What is the current consensus analyst rating for AbbVie?

AbbVie currently has 1 sell rating, 1 hold rating and 12 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ABBV will outperform the market and that investors should add to their positions of AbbVie.
View the latest ratings for ABBV.

What other companies compete with AbbVie?

How do I contact AbbVie's investor relations team?

AbbVie's physical mailing address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO IL, 60064. The company's listed phone number is (847) 932-7900. The official website for AbbVie is www.abbvie.com.